SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000; 124: 966-978.
  • 2
    Donegan WL. The influence of untreated internal mammary metastases upon the course of mammary cancer. Cancer. 1977; 39: 533-538.
  • 3
    Cody HS 3rd, Urban JA. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol. 1995; 2: 32-37.
  • 4
    Madsen E, Gobardhan P, Bongers V, et al. The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer. Ann Surg Oncol. 2007; 14: 1486-1492.
  • 5
    Klauber-DeMore N, Bevilacqua JL, Van Zee KJ, Borgen P, Cody HS 3rd. Comprehensive review of the management of internal mammary lymph node metastases in breast cancer. J Am Coll Surg. 2001; 193: 547-555.
  • 6
    Veronesi U, Marubini E, Mariani L, Valagussa P, Zucali R. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer. 1999; 35: 1320-1325.
  • 7
    Shahar KH, Buchholz TA, Delpassand E, et al. Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma. Cancer. 2005; 103: 1323-1329.
  • 8
    Colleoni M, Zahrieh D, Gelber RD, et al. Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience. J Clin Oncol. 2005; 23: 1390-1400.
  • 9
    Uren RF, Howman-Giles R, Renwick SB, Gillett D. Lymphatic mapping of the breast: locating the sentinel lymph nodes. World J Surg. 2001; 25: 789-793.
  • 10
    Yao MS, Kurland BF, Smith AH, et al. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer. Ann Surg Oncol. 2007; 14: 2985-2993.
  • 11
    Galimberti V, Veronesi P, Arnone P, et al. Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol. 2002; 9: 924-928.
  • 12
    Tanis PJ, Nieweg OE, Valdés Olmos RA, et al. Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients. Br J Cancer. 2002; 87: 705-710.
  • 13
    Estourgie SH, Tanis PJ, Nieweg OE, Valdés Olmos RA, Rutgers EJ, Kroon BB. Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol. 2003; 10: 935-941.
  • 14
    Greene FL, Page DL, Fleming ID, et al, editors. AJCC Cancer Staging Manual. 6th edition. New York, NY: Springer-Verlag; 2002.
  • 15
    Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg. 1985; 202: 702-707.
  • 16
    Urban JA, Marjani MA. Significance of internal mammary lymph node metastases in breast cancer. Am J Roentgenol Radium Ther Nucl Med. 1971; 111: 130-136.
  • 17
    Sugg SL, Ferguson DJ, Posner MC, Heimann R. Should internal mammary nodes be sampled in the sentinel lymph node era? Ann Surg Oncol. 2000; 7: 188-192.
  • 18
    Yu J, Li G, Li J, Wang Y. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields. Int J Radiat Oncol Biol Phys. 2005; 61: 874-878.
  • 19
    Noushi F, Spillane AJ, Uren RF, Gebski V. Internal mammary node metastasis in breast cancer: predictive models to determine status & management algorithms. Eur J Surg Oncol. 2010; 36: 16-22.
  • 20
    Johnson N, Soot L, Nelson J, et al. Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. Am J Surg. 2000; 179: 386-388.
  • 21
    Noguchi M, Tsugawa K, Miwa K. Internal mammary chain sentinel lymph node identification in breast cancer. J Surg Oncol. 2000; 73: 75-80.
  • 22
    Dupont E, Cox CE, Nguyen K, et al. Utility of internal mammary lymph node removal when noted by intraoperative gamma probe detection. Ann Surg Oncol. 2001; 8: 833-836.
  • 23
    van der Ent FW, Kengen RA, van der Pol HA, Povel JA, Stroeken HJ, Hoofwijk AG. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg. 2001; 234: 79-84.
  • 24
    Farrus B, Vidal-Sicart S, Velasco M, et al. Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan. Int J Radiat Oncol Biol Phys. 2004; 60: 715-721.
  • 25
    Mansel RE, Goyal A, Newcombe RG; ALMANAC Trialists Group. Internal mammary node drainage and its role in sentinel lymph node biopsy: the initial ALMANAC experience. Clin Breast Cancer. 2004; 5: 279-284.
  • 26
    Paredes P, Vidal-Sicart S, Zanón G, et al. Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients. Eur J Nucl Med Mol Imaging. 2005; 32: 1283-1287.
  • 27
    Carcoforo P, Sortini D, Feggi L, et al. Clinical and therapeutic importance of sentinel node biopsy of the internal mammary chain in patients with breast cancer: a single-center study with long-term follow-up. Ann Surg Oncol. 2006; 13: 1338-1343.
  • 28
    Veronesi U, Arnone P, Veronesi P, et al. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol. 2008; 19: 1553-1560.
  • 29
    Avisar E, Molina MA, Scarlata M, Moffat FL. Internal mammary sentinel node biopsy for breast cancer. Am J Surg. 2008; 196: 490-494.
  • 30
    Coombs NJ, Boyages J, French JR, Ung OA. Internal mammary sentinel nodes: ignore, irradiate or operate? Eur J Cancer. 2009; 45: 789-794.
  • 31
    Heuts EM, van der Ent FW, von Meyenfeldt MF, Voogd AC. Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients. Eur J Surg Oncol. 2009; 35: 252-257.
  • 32
    Domenech-Vilardell A, Bajen MT, Benitez AM, et al. Removal of the internal mammary sentinel node in breast cancer. Nucl Med Commun. 2009; 30: 962-970.
  • 33
    van Esser S, Madsen EV, van Dalen T, et al. Axillary staging in breast cancer patients with exclusive lymphoscintigraphic drainage to the internal mammary chain. World J Surg. 2011; 35: 159-164.
  • 34
    Spillane AJ, Noushi F, Cooper RA, Gebski V, Uren RF. High-resolution lymphoscintigraphy is essential for recognition of the significance of internal mammary nodes in breast cancer. Ann Oncol. 2009; 20: 977-984.
  • 35
    Chagpar AB, Kehdy F, Scoggins CR, et al. Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer. Am J Surg. 2005; 190: 557-562.
  • 36
    Buchholz TA. Internal mammary lymph nodes: to treat or not to treat. Int J Radiat Oncol Biol Phys. 2000; 46: 801-803.
  • 37
    Freedman GM, Fowble BL, Nicolaou N, et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys. 2000; 46: 805-814.
  • 38
    Whelan T, Olivotto I, Ackerman I, et al. NCIC-CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer [Abstract]. J Clin Oncol. 2011; 29( 18 Suppl): LBA1003.
  • 39
    Olivotto IA, Chua B, Elliott EA, et al. A clinical trial of breast radiation therapy versus breast plus regional radiation therapy in early-stage breast cancer: the MA20 trial. Clin Breast Cancer. 2003; 4: 361-363.